Literature DB >> 1403461

Nutritional rehabilitation in cystic fibrosis: a 5 year follow-up study.

A M Dalzell1, R W Shepherd, B Dean, G J Cleghorn, T L Holt, P J Francis.   

Abstract

Previously, we reported catch-up weight gain, growth, and improved lung function in a group of malnourished cystic fibrosis (CF) children receiving aggressive nutritional supplementation for 1 year compared with a forced expiratory volume in 1 s (FEV1)-, height-, and sex-matched comparison group receiving standard therapy. To evaluate long-term effects, the clinical progress of both groups has been studied over a 5 year period. The supplemented group (n = 10) received supplements for a median of 1.35 years to achieve nutritional rehabilitation. Compared with the nonsupplemented group (n = 14), the previously supplemented group had lower mortality (2 vs. 4, N.S.) and significantly greater weight and height z scores at 4 and 5 years. The progression of pulmonary function abnormalities as measured by FEV1 and forced vital capacity (FVC) slopes was greater at 3 years in the nonsupplemented group (FEV1, p less than 0.05) but no significant differences in rates of deterioration of pulmonary function were seen after 5 years in the two groups of survivors. We conclude that intensive nutritional support for 1 year has both short- and long-term effects on nutrition and growth, still evident some years after the cessation of this therapeutic modality. Supplementation for periods of longer than 1 year may produce greater gains and possibly prolong the improvement in pulmonary function observed in the earlier study.

Entities:  

Mesh:

Year:  1992        PMID: 1403461     DOI: 10.1097/00005176-199208000-00007

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  8 in total

Review 1.  Nutritional management of the infant with cystic fibrosis.

Authors:  M R Green; E Buchanan; L T Weaver
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

Review 2.  Pancreatic exocrine function in patients with cystic fibrosis.

Authors:  Susan S Baker; Drucy Borowitz; Robert D Baker
Journal:  Curr Gastroenterol Rep       Date:  2005-06

Review 3.  Nutritional management of cystic fibrosis.

Authors:  A MacDonald
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

4.  Increasing calorie consumption in children with cystic fibrosis: replication with 2-year follow-up.

Authors:  L J Stark; L G Knapp; A M Bowen; S W Powers; E Jelalian; S Evans; M A Passero; M M Mulvihill; M Hovell
Journal:  J Appl Behav Anal       Date:  1993

Review 5.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Alexandra L Haagensen; Ben Carter; Zbys Fedorowicz; Brian W Houston
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

6.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Ben Carter; Melissa Putman
Journal:  Cochrane Database Syst Rev       Date:  2018-12-17

7.  Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis.

Authors:  Susan S Baker
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

8.  Home Oxygen Therapy for Children. An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Don Hayes; Kevin C Wilson; Katelyn Krivchenia; Stephen M M Hawkins; Ian M Balfour-Lynn; David Gozal; Howard B Panitch; Mark L Splaingard; Lawrence M Rhein; Geoffrey Kurland; Steven H Abman; Timothy M Hoffman; Christopher L Carroll; Mary E Cataletto; Dmitry Tumin; Eyal Oren; Richard J Martin; Joyce Baker; Gregory R Porta; Deborah Kaley; Ann Gettys; Robin R Deterding
Journal:  Am J Respir Crit Care Med       Date:  2019-02-01       Impact factor: 21.405

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.